Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 55.60
+1.90 (3.54%)
At close: May 22, 2026
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 749.01 million as of May 22, 2026. Its market cap has decreased by -9.00% in one year.
Market Cap
749.01M
Enterprise Value
617.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
55.60
Market Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 749.01M, an increase of 299.49%. That is a compound annual growth rate of 14.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 749.01M | 10.10% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.34B |
| Xspray Pharma AB | 1.20B |
| Medivir AB | 1.10B |
| SynAct Pharma AB | 814.26M |
| Cantargia AB | 790.59M |
| Oncopeptides AB | 719.42M |
| FluoGuide | 671.96M |
| Corline Biomedical AB | 475.62M |